Godavari Biorefineries (GBL) is an integrated sugar company operating
in sugar, ethanol, bio-based chemicals and power.
GBL is one of the India’s largest producers of ethanol in terms of
volume as of March 31, 2024. It is also the largest manufacturer of3-methyl- 3-pentene-2-one(MPO)
worldwide in terms of installed capacity, one of only two manufacturers of
natural 1,3 butylene glycol and the only company in India to manufacture bio
ethyl acetate.
GBL has also set up first bio-based ethyl venyl ethers (EVE)
manufacturing facility in India as on March 31, 2024.
The company markets multiple products including sugar, jaggery, salt
and turmeric under its brand name `Jivana,’ which is distributed through retail
stores as well as online retail channels. Revenues from products sold under the
`Jivana’ brand increased from Rs 28.3 crore in FY22 to Rs 84.2 crore in FY24.
GBL has two manufacturing facilities, with one manufacturing
facilitylocated in the Bagalkot district in Karnataka (theSameerwadi
Manufacturing Facility) and anothermanufacturing facility located in the
Ahmednagar district in Maharashtra (theSakarwadi ManufacturingFacility). The
Sameerwadimanufacturing facility is an integrated facility dedicated to the
manufacturing ofethanol, sugar and power, while the Sakarwadimanufacturing facility
is currently dedicated to the manufacturingof bio-based chemicals. As at June
30, 2024, the Sameerwadimanufacturing facility had inter alia a
sugarcanecrushing capacity of 18,000 TCD, an installed capacity of 600 Kilo
Liter Per Day (KLPD) for rectified spirits, 570 KLPD of ethanol and power
plants with anaggregate installed capacity of 45.56 MW, while at the Sakarwadimanufacturing
facility, the aggregate installedcapacity for its bio-based chemicals including
ethyl acetate, acetaldehyde, acetic acid, 3-methyl 3 penteneone (MPO), 1,3 BG, crotonaldehyde
and paraldehyde and others was 117,826.20 MTPA.
The company has research & development (R&D) facility with one
R&D Facility located at the Sakarwadi manufacturing facility, onelocated at
the Sameerwadi manufacturing facility and one located in Navi Mumbai,
Maharashtra.
The company utilizes sugarcane as a feedstock to manufacture its
products and is in the process of exploring the utilization of grains to
manufacture grain-based ethanol.
Products of the company find application in industries including
food,beverages, pharmaceuticals, flavors& fragrances, power, fuel, personal
care and cosmetics. Some of its clients
include marquee players such as Hershey India Pvt Ltd, Hindustan Coca-Cola
Beverages Private Limited, Karnataka Chemical Industries, Techno Waxchem Pvt
Ltd, Ankit Raj Organo Chemicals Limited, Escorts Chemical Industries, Khushbu
Dye Chem Pvt Ltd, PriviSpeciality Chemicals, Shivam Industries, as well as
major oil marketing companies.
GBL exports its products to over 20 countries including Australia,
China, Germany, France, Italy Japan, Kenya, Netherlands, Singapore, United
Kingdom, United Arab Emirates, Indonesia and United States of America. It has
also established offices in Hoofddorp (Netherlands) and Philadelphia (United
States of America). Revenue from exports stood at 79.67 crore and Rs 280.9
crore respectively for 3 months ended June 30, 2024 and for FY2024
respectively.
Object of the
offer
The IPO consists of a fresh issue of Rs 325 crore and an
offer-for-sale(OFS) of up to 6526983 shares by its existing shareholders. The
OFS comprises up to 4926983 shares by Mandala Capital AG Limited and the
balance 16,00,000 shares by promoter and promoter group companies.
Out of the proceeds from the fresh issue, Rs 240 crore will be used for
repayment, prepayment and redemption, in full or in part, of certain borrowings
availed of by the company and the balance for general corporate purposes.
Strengths
The company has location advantage as its sugarcane crushing facility are
located at Sameerwadi, Karnataka along with distillery and co-gen power plant.
Besides,the company also has another manufacturing plant engaged in production
of chemical products at Sakarwadi, Maharashtra.Sugarcane of Maharashtra and
Karnataka has higher recovery than cane in other regions of India, which
provides companies withmanufacturing facilities in this region better
operational benefits.
The revenue profile of GBL is diversified characterized by its presence
in production of sugar, ethanol, power and chemicals. Further, the company has
well-established relationship with customer base across industries and
geographies.
As on March 31,2024, the company is one of the largest producers of
ethanol in terms of volume. It is also the largest manufacturer of MPO
worldwide in terms of installed capacity.
The company has well-developed in-house research and development
(R&D) capabilities with R&D facilities which are registered with the
Department of Scientific and Industrial Research, Government of India. The
company has consistently invested in R&D and technology and has
successfully implemented some of the process improvements and product
developments at its manufacturing facilities over the years. During the three
months ended June 30, 2024, and FY 2024, 2023 and 2022, its has incurred
research and development expenditureaggregating to Rs 2.5 crore, Rs 14.4 crore,
Rs 17.0 crore and Rs 13.4 crore million, respectively.
The company is part of the Somaiya group, which has diversified
interests in inter alia the biorefinery, agriculturalresearch, education and
healthcare industries. The group has a well experienced Board, which is
supported by qualified functional heads and key managerial personnel and senior
management who actively contribute to and participate in its strategies,
operations and business development.
Weaknesses
The company faces supplier concentration risk as it procures
significant portion of its raw materials (excluding sugarcane) from a few suppliers.
Raw material constitutes around 70% of the total revenue for the
company as such margins of the company are susceptible to fluctuation in raw
material prices.
The company is dependent on a limited number of customers (oil
marketing companies for ethanol) for a portion of its revenues and does not
enter long-term supply agreements with key customers resulting in customer
concentration risk.
There are certain outstanding legal proceedings involving the company
and some of its promoters and directors. Aggregate amount of claims against the
company stood at Rs 132.8 crore and against the promoters stood at Rs 2.7
crore.
SEBI has in the past directed the company to refund amounts received
pursuant to certain allotments to Sameerwadi Sugarcane Farmers’ Welfare Trust
or to pro rata distribute Equity Shares, to beneficiaries of the Sameerwadi
Sugarcane Farmers’ Welfare Trust. Any regulatory or legal proceedings in the
future may adversely affect the financial condition of the company.
The company is dependent on third party manufacturers for the
manufacture and sale of products under its retail brand ‘Jivana’. Any
disruption in such third party manufacturers’ ability to supply these products
or their failure to meet the quality standards or delivery timelines could
adversely affect the company’s business.
Operations of the company are working capital intensive and
insufficient cash flows may have adverse effect on the operations of the
company.
Contingent liabilities as on June 30,2024 stood at Rs 206.5 crore.
Valuation
For the three months ended June 30, 2024, the company incurred net loss
of Rs 26.1 crore on revenues of Rs 522.
Sales were down by 16.3% to Rs 554.41 crore in FY 2024.The OPM increased
by 66 bps. However,OP decreased by 8.7% to Rs 133.54 crore. OI increased 71.7%
to Rs 14.40 crore. Interest costsrose3.8% to Rs 75.56 crore. Depreciation increased
19.7% to Rs 59.93 crore. PBTstood at Rs 12.45 crore as against Rs 31.75 crore in
FY2023. Net profit stood at Rs 12.30 crore as against net profit of Rs 19.64 crore.
At the higher price band of Rs 352, the offer is made at a P/E of 146.47
times FY2024 EPS (EPS of Rs 2.4).
The total outstanding borrowings were Rs 693.7 crore on a consolidated
basis as of 30June 2024. The plan is to repay 34.6% of the debt using the issue
proceeds. This will significantly reduce interest costs and boost profits. The
FY2024 EPS would be Rs 7.5 if 34.6% of the interest cost is eliminated,
assuming all other factors, including the tax rate, remain unchanged. The
adjusted P/E ratio, at the upper price band, moderates to 47.2.
Listed industry peers are EID Parry (India), Triveni Engineering and
Industries, Balrampur Chini Mills, Dalmia Bharat Sugar & Industries and
Dwarkish Sugar Industries.In comparison,EID Parry (India) trades at 16 times
its P/TTM EPS(TTM EPS Rs 49.69), Triveni Engineering and Industries trades at 26
times its P/TTM EPS (TTM EPS Rs 16.4), Balrampur Chini Mills trades at 24 times
its P/TTM EPS (TTM EPS Rs 26.33), Dalmia Bharat Sugar and Industries trades at
15 times P/TTM EPS( TTM EPS Rs 32.87) and Dwarkish Sugar trades at 40 times it
P/TTM EPS(TTM EPS Rs 1.75).
Godavari Biorefineries: Issue
highlights
|
For Fresh Issue Offer size (in no
of shares )
|
|
- On lower price band
|
9730539
|
- On upper price band
|
9232955
|
Offer size (in Rs crore)
|
325
|
For Offer for Sale Offer size (in
no of shares )
|
|
- On lower price band
|
6526983
|
- On upper price band
|
6526983
|
Offer size (in Rs crore)
|
543-553
|
Price band (Rs)
|
334-352
|
Minimum Bid Lot (in no. of shares )
|
42
|
Post issue capital (Rs crore)
|
|
- On lower price band
|
51.18
|
- On upper price band
|
51.67
|
Post-issue promoter & Group
shareholding (%)
|
53.68%
|
Issue open date
|
23-10-2024
|
Issue closed date
|
25-10-2024
|
Listing
|
BSE, NSE
|
Rating
|
40/100
|
Godavari
Biorefineries : Consolidated Financials
|
|
2203 (12)
|
2303 (12)
|
2403 (12)
|
2406 (3)
|
Sales
|
1702.33
|
2014.69
|
1686.67
|
522.53
|
OPM (%)
|
7.81
|
7.26
|
7.92
|
-2.34
|
OP
|
132.89
|
146.23
|
133.54
|
-12.24
|
Other inc.
|
7.65
|
8.39
|
14.40
|
2.75
|
PBIDT
|
140.54
|
154.62
|
147.93
|
-9.49
|
Interest
|
60.44
|
72.79
|
75.56
|
19.57
|
PBDT
|
80.09
|
81.83
|
72.37
|
-29.07
|
Dep.
|
48.03
|
50.08
|
59.93
|
12.57
|
PBT
|
32.07
|
31.75
|
12.45
|
-41.64
|
Share of profit/loss from JV
|
-
|
-
|
-
|
-
|
PBT Before EO
|
32.07
|
31.75
|
12.45
|
-41.64
|
Exceptional items
|
-
|
-
|
-
|
-
|
PBT After EO
|
32.07
|
31.75
|
12.45
|
-41.64
|
Total Tax
|
12.97
|
12.11
|
0.15
|
-15.53
|
PAT
|
19.10
|
19.64
|
12.30
|
-26.11
|
Minority Interest
|
-
|
-
|
-
|
-
|
Net Profit
|
19.10
|
19.64
|
12.30
|
-26.1
|
EPS (Rs)*
|
3.7
|
3.8
|
2.4
|
#
|
EPS is on post issue equity capital of Rs 51.18 crore of face
value of Rs 10 each
|
Figures in Rs crore
|
Source:Godavari Biorefineries Issue
Prospectus
|
|